Immunodeficiency due to mutations in ORAI1 and STIM1

Area of Science:

• Immunology
• Cell Biology
• Genetics

Background:

• Lymphocyte activation critically depends on calcium (Ca2+) influx via plasma membrane channels.
• The Ca2+ release-activated Ca2+ (CRAC) channel, encoded by ORAI1, is central to T cell activation.
• ORAI1 is regulated by stromal interaction molecule 1 (STIM1), which senses ER Ca2+ levels.

Purpose of the Study:

• To review the immunological and non-immunological phenotypes associated with defects in store-operated Ca2+ entry (SOCE) and CRAC channel function.
• To discuss these patient phenotypes in the context of related immunodeficiency diseases.
• To explore findings from animal models of ORAI1 and STIM1 function.

Main Methods:

• Review of clinical data from patients with ORAI1 and STIM1 gene mutations.
• Analysis of immunological assays assessing T cell activation.
• Comparison with established immunodeficiency diseases and animal models.

Main Results:

• Mutations in ORAI1 and STIM1 cause a distinct phenotype including immunodeficiency, muscular hypotonia, and ectodermal dysplasia.
• Immunodeficiency stems from defective T cell activation, not lymphocyte development.
• STIM1 deficiency is also linked to autoimmunity and lymphoproliferative disease.

Conclusions:

• Defects in SOCE and CRAC channel function due to ORAI1/STIM1 mutations lead to significant clinical manifestations.
• Understanding these defects provides insights into T cell activation pathways and related diseases.
• Further research in animal models can elucidate the complex roles of ORAI1 and STIM1.